<DOC>
	<DOCNO>NCT02969447</DOCNO>
	<brief_summary>Prospective randomize trail compare 2 regimens third-stage management second trimester medical pregnancy termination : 10UI intra venous oxytocin additional medication fetal expulsion . Primary outcome incidence placental retention .</brief_summary>
	<brief_title>Management Third-stage Labor After Second Trimester Medical Pregnancy Termination</brief_title>
	<detailed_description>Complication third stage labor second trimester medical pregnancy termination well study . Accord publication , placental retention rate 30 40 % situation . Placental retention may associate increase blood loss , increase requirement blood transfusion anesthetic operative complication , infectious morbidity . The high incidence retain placenta area clinical concern . Publications reveal wide variation practice study third stage labor second trimester medical pregnancy termination . The study prospective randomize trial . Two third stage management strategy compare : 10 unit intra venous oxytocin ( group 1 ) additional medication ( group 2 ) fetal expulsion . It concern pregnancy 14 28 week gestation .</detailed_description>
	<mesh_term>Placenta , Retained</mesh_term>
	<mesh_term>Oxytocin</mesh_term>
	<criteria>18 year old old medical pregnancy termination 14 28 week gestation inform consent obtain less 18 year old refusal consent utero fetal death</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Retained Placenta</keyword>
	<keyword>Second trimester medical termination</keyword>
	<keyword>Third stage labor</keyword>
	<keyword>Oxytocin</keyword>
</DOC>